Working… Menu

Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients (OnceDaily)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02426502
Recruitment Status : Active, not recruiting
First Posted : April 27, 2015
Last Update Posted : October 7, 2021
Astellas Pharma Canada, Inc.
Information provided by (Responsible Party):
John Gill, University of British Columbia

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022